INTEGRATION OF ADME/PK INTO HIT-TO-LEAD DRUG DISCOVERY

被引:0
作者
Lin, Jing [1 ]
机构
[1] Pfizer Inc, Pharmacokinet Dynam & Metab, Groton, CT 06340 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
5
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
[21]   HTS carving out hit-to-lead position [J].
Flanagan, Nina .
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (08) :20-+
[22]   Designing focused libraries for drug discovery: Hit to lead to drug [J].
Tropsha, A ;
Reynolds, CH .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (06) :427-428
[23]   Discovery of potent dipeptidyl peptidase IV inhibitors through pharmacophore hybridization and hit-to-lead optimization [J].
Zeng, Shaogao ;
Xie, Hui ;
Zeng, Li-li ;
Lu, Xin ;
Zhao, Xin ;
Zhang, Gui-cheng ;
Tu, Zheng-chao ;
Xu, Hong-jiang ;
Yang, Ling ;
Zhang, Xi-quan ;
Hu, Wenhui .
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (07) :1749-1755
[24]   Identification and In-Vitro ADME Assessment of a Series of Novel Anti-Malarial Agents Suitable for Hit-to-Lead Chemistry [J].
Edlin, Chris D. ;
Morgans, Garreth ;
Winks, Susan ;
Duffy, Sandra ;
Avery, Vicky M. ;
Wittlin, Sergio ;
Waterson, David ;
Burrows, Jeremy ;
Bryans, Justin .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (07) :570-573
[25]   A novel series of positive modulators of the AMPA receptor: Discovery and structure based hit-to-lead studies [J].
Jamieson, Craig ;
Basten, Stephanie ;
Campbell, Robert A. ;
Cumming, Iain A. ;
Gillen, Kevin J. ;
Gillespie, Jonathan ;
Kazemier, Bert ;
Kiczun, Michael ;
Lamont, Yvonne ;
Lyons, Amanda J. ;
Maclean, John K. F. ;
Moir, Elizabeth M. ;
Morrow, John A. ;
Papakosta, Marianthi ;
Rankovic, Zoran ;
Smith, Lynn .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) :5753-5756
[26]   Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors [J].
Baxter, A ;
Brough, S ;
Cooper, A ;
Floettmann, E ;
Foster, S ;
Harding, C ;
Kettle, J ;
McInally, T ;
Martin, C ;
Mobbs, M ;
Needham, M ;
Newham, P ;
Paine, S ;
St-Gallay, S ;
Salter, S ;
Unitt, J ;
Xue, YF .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) :2817-2822
[27]   The discovery of CCR5 receptor antagonists for the treatment of HIV infection: Hit-to-lead studies [J].
Armour, Duncan ;
de Groot, Marcel J. ;
Edwards, Martin ;
Perros, Manos ;
Price, David A. ;
Stammen, Blanda L. ;
Wood, Anthony .
CHEMMEDCHEM, 2006, 1 (07) :706-+
[28]   The discovery of aminopyrazines as novel, potent Nav1.7 antagonists: Hit-to-lead identification and SAR [J].
Bregman, Howard ;
Hanh Nho Nguyen ;
Feric, Elma ;
Ligutti, Joseph ;
Liu, Dong ;
McDermott, Jeff S. ;
Wilenkin, Ben ;
Zou, Anruo ;
Huang, Liyue ;
Li, Xingwen ;
McDonough, Stefan I. ;
DiMauro, Erin F. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) :2033-2042
[29]   The hit-to-lead process at Schering AG: strategic aspects [J].
Steinmeyer, Andreas .
CHEMMEDCHEM, 2006, 1 (01) :31-36
[30]   Novel Triazeneindole Antibiotics: Synthesis and Hit-to-Lead Optimization [J].
Sorokin, Boris ;
Filimonova, Alla ;
Emelianova, Anna ;
Kublitski, Vadim ;
Gvozd, Artem ;
Shmygarev, Vladimir ;
Yampolsky, Ilia ;
Guglya, Elena ;
Gusev, Evgeniy ;
Kuzmin, Denis .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)